311 related articles for article (PubMed ID: 33803026)
1. Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome.
Shimizu T; Nakamura H; Kawakami A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803026
[TBL] [Abstract][Full Text] [Related]
2. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
Mavragani CP
Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
[TBL] [Abstract][Full Text] [Related]
4. Protocols for Experimental Sjögren's Syndrome.
Bagavant H; Deshmukh US
Curr Protoc Immunol; 2020 Dec; 131(1):e114. PubMed ID: 33252847
[TBL] [Abstract][Full Text] [Related]
5. Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiation.
Kramer JM
Cytokine; 2014 Jun; 67(2):92-101. PubMed ID: 24656928
[TBL] [Abstract][Full Text] [Related]
6. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
7. Aspects of innate immunity in Sjögren's syndrome.
Low HZ; Witte T
Arthritis Res Ther; 2011 May; 13(3):218. PubMed ID: 21635716
[TBL] [Abstract][Full Text] [Related]
8. Activation of the type I interferon pathway in primary Sjogren's syndrome.
Mavragani CP; Crow MK
J Autoimmun; 2010 Nov; 35(3):225-31. PubMed ID: 20674271
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity in Sjögren's syndrome.
Kiripolsky J; McCabe LG; Kramer JM
Clin Immunol; 2017 Sep; 182():4-13. PubMed ID: 28396235
[TBL] [Abstract][Full Text] [Related]
10. B cell toll-like receptors with respect to the pathogenesis of Sjögren's syndrome.
Berglová I; Krejsek J; Kolácková M; Slezák R
Acta Medica (Hradec Kralove); 2011; 54(2):51-7. PubMed ID: 21842717
[TBL] [Abstract][Full Text] [Related]
11. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
[TBL] [Abstract][Full Text] [Related]
12. The Involvement of Innate and Adaptive Immunity in the Initiation and Perpetuation of Sjögren's Syndrome.
Chivasso C; Sarrand J; Perret J; Delporte C; Soyfoo MS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440862
[TBL] [Abstract][Full Text] [Related]
13. Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation.
Manoussakis MN; Spachidou MP; Maratheftis CI
J Autoimmun; 2010 Nov; 35(3):212-8. PubMed ID: 20685081
[TBL] [Abstract][Full Text] [Related]
14. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.
Srivastava A; Makarenkova HP
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271951
[TBL] [Abstract][Full Text] [Related]
15. Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren's syndrome?
Barrera MJ; Aguilera S; Veerman E; Quest AF; Díaz-Jiménez D; Urzúa U; Cortés J; González S; Castro I; Molina C; Bahamondes V; Leyton C; Hermoso MA; González MJ
Rheumatology (Oxford); 2015 Aug; 54(8):1518-27. PubMed ID: 25802401
[TBL] [Abstract][Full Text] [Related]
16. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.
Ushio A; Arakaki R; Otsuka K; Yamada A; Tsunematsu T; Kudo Y; Aota K; Azuma M; Ishimaru N
Front Immunol; 2018; 9():2594. PubMed ID: 30467506
[TBL] [Abstract][Full Text] [Related]
17. TLR7 Signaling Drives the Development of Sjögren's Syndrome.
Wang Y; Roussel-Queval A; Chasson L; Hanna Kazazian N; Marcadet L; Nezos A; Sieweke MH; Mavragani C; Alexopoulou L
Front Immunol; 2021; 12():676010. PubMed ID: 34108972
[TBL] [Abstract][Full Text] [Related]
18. Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome.
Sekiguchi M; Iwasaki T; Kitano M; Kuno H; Hashimoto N; Kawahito Y; Azuma M; Hla T; Sano H
J Immunol; 2008 Feb; 180(3):1921-8. PubMed ID: 18209090
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
20. Activation of the type I interferon pathway in primary Sjögren's syndrome: an update.
Vakaloglou KM; Mavragani CP
Curr Opin Rheumatol; 2011 Sep; 23(5):459-64. PubMed ID: 21760509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
